about
Electroclinical features of epilepsy in patients with InvDup(15).Migralepsy and related conditions: advances in pathophysiology and classification.Memory impairment and Benign Epilepsy with centrotemporal spike (BECTS): a growing suspicion.Current advances in childhood absence epilepsy.Refractory absence epilepsy and glut1 deficiency syndrome: a new case report and literature review.Transition into adulthood: tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis.Neuropsychological impairment in childhood absence epilepsy: Review of the literature.Refractory absence seizures: An Italian multicenter retrospective study.Hemispherotomy in Rasmussen encephalitis: long-term outcome in an Italian series of 16 patients.Reflex myoclonic epilepsy in infancy: a multicenter clinical study.Topiramate: effects on serum lipids and lipoproteins levels in children.Electroclinical findings and long-term outcomes in epileptic patients with inv dup (15).The dilemma of adult-onset Rasmussen encephalitis clinical assessment: Proposal for a new bedside tool to evaluate disease progression.Palliative non-resective surgery for drug-resistant epilepsy.Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.Clinical dissection of childhood occipital epilepsy of Gastaut and prognostic implication.Symptomatic and presumed symptomatic focal epilepsies in childhood: An observational, prospective multicentre study.Perisylvian, including insular, childhood epilepsy: Presurgical workup and surgical outcome.Long-term outcome of epilepsy in patients with Prader-Willi syndrome.Epilepsy in Menkes disease: an electroclinical long-term study of 28 patients.Epilepsy in the setting of full trisomy 18: A multicenter study on 18 affected children with and without structural brain abnormalities.Clinical manifestations in children and adolescents with corpus callosum abnormalities.Pediatric NMDAR encephalitis: A single center observation study with a closer look at movement disorders.Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis.An unusual behavioural and motor paroxysmal disorder caused by insulinoma-related hypoglycemia: a possible cause of epilepsy misdiagnosis.Neuropsychological profiles and outcomes in children with new onset frontal lobe epilepsy.Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disordersErratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndromeFocal seizure, focal dyskinesia, or both? A complex motor phenomenon reveals anti-NMDAR encephalitisBone metabolism and vitamin D levels in carbamazepine-treated patientsElectroclinical features of epilepsy monosomy 1p36 syndrome and their implicationsPharmacokinetic considerations for anti-epileptic drugs in childrenEpileptic phenotypes in children with early-onset mitochondrial diseasesPolysomnographic Findings in Fragile X Syndrome Children with EEG AbnormalitiesRelapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis
P50
Q36323157-00075F25-196D-4FA3-A26E-91CDF73CAF53Q37856540-767D101C-D5FF-4AF0-8C3A-9832279E13C5Q38173229-DE39E7A6-0D25-4E73-9B91-2AE68C3CB925Q38188273-258C4A41-8730-44B9-9CCB-64B5EFDA9727Q38217279-AAA83990-CFD9-4A44-A8A1-7B9633800812Q38248203-8AE1768A-1D34-4DB7-A3C7-5442FCD57D93Q38670308-94E8610D-87A3-4664-804E-2485343204C3Q41518007-A87C88BD-EB4D-41E2-9BDC-C35679049C32Q43605320-462CD65D-8A68-4DA9-8478-65DE71B66D08Q45270010-8EF61FDC-A3FD-4DB0-A0DB-2C493C465AD4Q46966677-AD974698-F0C5-4B1D-A148-2F3B5B90279BQ47552540-1F8A75CB-4BB3-4A99-9929-0EFFE7A84E55Q47702033-7123A08B-28DA-4EE8-9352-5D3765791563Q47859876-2A1325B4-DDB1-4AE6-8969-8AC5C29D6130Q47890640-572B5808-417E-4FC2-BC37-0E180B578665Q47924351-DCE326D5-4328-4F54-BBF0-BCF028F98CE7Q47974880-77C88B45-4A2A-4C00-B399-0BB962F6A546Q48227424-EC2B7C24-E628-4924-B58D-947A7CFD9434Q48481543-BACA55C5-443C-4B77-B67E-C8034CB03EB4Q48545381-A4BE8464-71A8-4B4F-88FB-12AF6BA6DFCFQ48573460-DF32F2BA-5741-4C51-990A-39FCD9FE78CFQ48636804-5C1C102E-5288-49CB-BA33-58723E159920Q49361266-21E1361D-A885-488D-801C-CEF8AB602CAAQ50231302-6BEFF6AC-FEEE-461D-AC02-E9CB39C35481Q50629727-32B56353-675A-48A8-8C56-256021D08115Q50677182-B41DFCA9-D627-4E01-A593-D8439AFF113BQ56770839-960E9E9A-088C-4B24-8CD1-B0A37D967E72Q59828682-FE3E6E6D-9EBE-45FF-924F-0801E169D4B2Q61922527-7AEB1B34-6F45-4FA0-BC72-BC21C6EDC136Q80281125-9A63C76C-AC52-4BC0-8298-15557E3B24D9Q90954751-373A7850-0272-4B75-BF75-3B8301884494Q91249972-8B697783-4032-4613-B2D5-02CAF8038A80Q92130115-247784A9-92ED-4AE2-B224-FE90E8DAC758Q92308939-4F0E3FCD-F4E2-4BE6-B03D-CF93E06D8E10Q92598799-F0842B0A-9736-47B0-8EE9-09DF13E058B6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sara Matricardi
@en
Sara Matricardi
@nl
type
label
Sara Matricardi
@en
Sara Matricardi
@nl
prefLabel
Sara Matricardi
@en
Sara Matricardi
@nl
P31
P496
0000-0002-4403-6342